iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench
30 Oct 2012

iCell Neurons derived from induced pluripotent stem cells (iPSCs) overcome existing models’ limitations in functionality, purity and reproducibility and offer a virtually unlimited supply of well-characterized cells for drug efficacy screening and safety testing. Importantly, using the iPSC technology to produce neurons enable more biologically relevant disease modeling, improved drug screening strategies, and forward movement toward personalized medicine.

Cellular Dynamics International



Show    per page
1 of 2 Page     1 2 Next 
Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications21 May 2013Read
CAP Releases First Evidence-Based Guideline for Validating Whole Slide Imaging (WSI)15 May 2013Read
Improve Efficiency of Variant Screening for Biological Drugs2 May 2013Read
Automated TruSeq RNA Sample Preparation from FFPE tissue21 Dec 2012Read
iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench30 Oct 2012Read
RNA-Seq Alignment and Analysis24 Oct 2012Read
Coating Techniques for Electron Microscopy – Obtain the Best Images Possible9 Oct 2012Read
Do you know what's in your laboratory water?1 Oct 2012Read
What's New in Lasergene 10.124 Sep 2012Read
Multiplexed High Content Hepatotoxicity Assays using iPSC-Derived Hepatocytes18 Sep 2012Read

Buying guides

Write a Review

Join 200,000 Scientists Online

Become a member for FREE for access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today